Do EU5 Countries with Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.071
https://www.valueinhealthjournal.com/article/S1098-3015(17)30405-9/fulltext
Title : Do EU5 Countries with Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30405-9&doi=10.1016/j.jval.2017.08.071
First page : A409
Section Title : BREAKOUT SESSION XIV
Open access? : No
Section Order : 54
Categories :
Tags :
Regions :
ViH Article Tags :